Research Article
Comparison between the Express Implant and Transscleral Diode Laser in Neovascular Glaucoma
Table 1
Demographic data and baseline clinical findings.
| | Groups | value | Group A (n = 12 eyes) (12 patients) | Group B (n = 18 eyes) (16 patients) | No. | % | No. | % |
| Age (mean ± SD) | 48.66 ± 4.81 | 46.25 ± 5.49 | 0.926 | Gender | | | | | 0.508 | Male | 6 | 50.0 | 6 | 62.5 | | Female | 6 | 50.0 | 10 | 37.5 | | Preoperative medications | | | | | 0.711 | Topical (beta-blocker + CAI) | 5 | 41.7 | 6 | 33.3 | | Topical (beta-blocker + CAI + brimonidine) | 7 | 58.3 | 12 | 66.7 | | Preoperative BCVA | | | | | | 1/60–6/60 | 8 | 58.3 | 11 | 61.1 | 1.0 | Better than 6/60 | 4 | 41.7 | 7 | 39.9 | | Grading of NVI (Teich and Walsh, 1981) [14] | | | | | | 0 no NVI | — | — | — | — | | 1 < 2 quadrants of NV at the iris pupillary zone | — | — | — | — | | 2 > 2 quadrants of NV at the iris pupillary zone | 7 | 58.3 | 11 | 61.1 | 1.0 | 3 Grade 2 + <3 quadrants of NV at the iris ciliary zone and/or ectropion uveae | 5 | 41.7 | 7 | 39.9 | | 4 > 3 quadrants of NV at the iris ciliary zone and/or ectropion uveae | | | | | | Causes of NVG | | | | | | PDR | 8 | 66.7 | 11 | 61.1 | 1.0 | CRVO | 4 | 33.3 | 7 | 39.9 | | Pre-PRP | 8 | 66.7 | 12 | 66.7 | 1.0 | Previous cataract surgery | 7 | 58.3 | 9 | 50.0 | 0.654 |
|
|